Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Net Income (2017 - 2025)

Arcus Biosciences (RCUS) has 9 years of Net Income data on record, last reported at -$164.0 million in Q4 2025.

  • For Q4 2025, Net Income changed N/A year-over-year to -$164.0 million; the TTM value through Dec 2025 reached -$276.0 million, changed N/A, while the annual FY2025 figure was -$353.0 million, 24.73% down from the prior year.
  • Net Income reached -$164.0 million in Q4 2025 per RCUS's latest filing, down from -$112.0 million in the prior quarter.
  • Across five years, Net Income topped out at $279.5 million in Q4 2021 and bottomed at -$164.0 million in Q4 2025.
  • Average Net Income over 5 years is -$58.0 million, with a median of -$75.0 million recorded in 2023.
  • The widest YoY moves for Net Income: up 637.62% in 2021, down 4379.64% in 2021.
  • A 5-year view of Net Income shows it stood at $279.5 million in 2021, then tumbled by 123.97% to -$67.0 million in 2022, then dropped by 20.9% to -$81.0 million in 2023, then dropped by 13.58% to -$92.0 million in 2024, then crashed by 78.26% to -$164.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were -$164.0 million in Q4 2025, -$112.0 million in Q1 2025, and -$92.0 million in Q3 2024.